Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Faisal Almutawa
Observed names:
Faisal M. Almutawa,
Faisal Mohammed Almutawa
Institutions:
King Saud bin Abdulaziz University for Health Sciences,
King Faisal Specialist Hospital & Research Centre
Observed institutions:
King Saud bin Abdulaziz University for Health Sciences,
King Faisal Specialist Hospital & Research Centre,
King Abdullah International Medical Research Center
ORCID:
0009-0009-0418-8323
Observed ORCID:
0009-0009-0418-8323
OpenAlex ID:
A5115425013
Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study
2024
·
Mohammed Bayounis
, Mohammed Bin Mahfooz
, et al.
·
Frontiers in Neurology
·
3
PDF
Use of Semaglutide in Diabetes Care Post Renal Transplantation
2025
·
Omar Buraykan Alluhayyan
, Faisal Mohammed Almutawa
, et al.
·
Current Transplantation Reports
·
1
EP58 - ECE_1318 - Risk factors and outcomes of critical illness-related corticosteroid insufficiency
2026
·
Moeber Mahzari
, Omar Alluhayyan
, et al.
·
European Journal of Endocrinology
PDF
Abstract Number: Esoc2026a1692 Is Age a Prognostic or Predictive Factor? a Study-level and Kaplan–meier–derived Individual Patient Data Meta-analysis of Pfo Closure in Adults Aged ≥60 Years
2026
·
Ahmed Alkhiri
, Fahad Alturki
, et al.
·
European Stroke Journal
Abstract TP046: Major Stroke Adverse Events of Dual Versus Single Anti-Platelet Therapy in Acute and Sub-acute Ischemic Stroke Patient Outcomes: A Retrospective Cohort Analysis
2026
·
Faisal Alamri
, Eman Alraddadi
, et al.
·
Stroke
Real-World Comparative Outcomes of Dual vs. Single Antiplatelet Therapy in Acute Ischemic Stroke: A Retrospective Cohort Analysis
2026
·
Yasser Alatawi
, Faisal F. Alamri
, et al.
·
Neurology and Therapy
PDF
Psychometric Validation of the Arabic Version of the WPAI:Migraine Questionnaire in Patients with Migraine
2025
·
Abdulrazaq Albilali
, Rema A. Almutawa
, et al.
·
Neurology International
PDF
53. Risk of Malignancy and the Use of Disease-Modifying Therapy in Multiple Sclerosis: Exploring the Role of DMT in a Multi-Center Study
2024
·
Mohammed Bayounis
, Mohammed Bin Mahfooz
, et al.
·
Multiple Sclerosis and Related Disorders
Association between gastroesophageal reflux disease and irritable bowel syndrome: a systematic review and meta-analysis
2024
·
Abdullah Alharbi
, Khalid Altaleb
, et al.
·
International Journal of Medicine in Developing Countries
Show more works
View as search
Works count:
9
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type